Cargando…
One Small Step for Empagliflozin, One Giant Leap for Diabetology
This article discusses the recently published EMPA-REG OUTCOME trial, which assessed cardiovascular outcomes with empagliflozin therapy in persons with type 2 diabetes mellitus and coexisting cardiovascular disease. The article describes the background and challenges of modern cardiovascular outcome...
Autor principal: | Kalra, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674475/ https://www.ncbi.nlm.nih.gov/pubmed/26537704 http://dx.doi.org/10.1007/s13300-015-0144-9 |
Ejemplares similares
-
One small wearable, one giant leap for patient safety?
por: Michard, Frederic, et al.
Publicado: (2021) -
One small step can lead to one giant leap
por: Frumovitz, Michael, et al.
Publicado: (2022) -
Diabetic Foot Ulcer Microbiome: One Small Step for Molecular Microbiology . . . One Giant Leap for Understanding Diabetic Foot Ulcers?
por: Lipsky, Benjamin A., et al.
Publicado: (2013) -
One Giant Leap for Categorizers: One Small Step for Categorization Theory
por: Smith, J. David, et al.
Publicado: (2015) -
One Small Step for a Patient, One Giant Leap for Orthostatic Hypotension
por: Coniglio, Amanda C, et al.
Publicado: (2022)